<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03222375</url>
  </required_header>
  <id_info>
    <org_study_id>SQUED™ series 28.1 home-use</org_study_id>
    <nct_id>NCT03222375</nct_id>
  </id_info>
  <brief_title>SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism</brief_title>
  <acronym>SQUED™</acronym>
  <official_title>The Home-Use of Semiconducting QUantum Excitonic Device: Image Converter/Sound Converter/Electromagnetic Converter to Improve Communicative Efforts, Speech, Language and Related Cognitive Functions in Children With Autism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American Federation of Medical Synergetics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute of Medical Synergetics, Department of Cognitive Neurology WOMS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratory of Neurocomputational Active Media WOMS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SQUED, Inc., USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Center of Synergetics, Universität Stuttgart, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ivan Franko National University of Lviv, Ukraine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danylo Halytsky Lviv National Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>World Organization of Medical Synergetics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>World Autism Center, American Federation of Medical Synergetics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>American Federation of Medical Synergetics</source>
  <oversight_info>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Locomotor, transport and information functions in human body systems are carried out by&#xD;
      active media in autowave regimes! Any living organism is a (micro-macro-mega) hierarchy of&#xD;
      autowave subsystems-an ensemble of loosely coupled subsystems of a simpler structure. From&#xD;
      the highest levels of the hierarchy, Autowave Codes-Signals arrive, which determine the&#xD;
      transitions of subsystems from one autowave regime to another Autowave interaction (of&#xD;
      Complex Coherent Action). Autowave interaction is a process associated with the evolution and&#xD;
      interaction of spatial and wave structures in the active media of the organism.&#xD;
&#xD;
      Chaos in organism functioning tells about health. Periodicity - Autowave reverberator may&#xD;
      presage a disease - Autism Spectrum Disorder; Chaotic nature of oscillations in active media&#xD;
      of physiological systems is more optimal for their vital functions than periodic one.&#xD;
      Firstly, systems that function in chaotic regimes, can re-arrange themselves faster and&#xD;
      easier in case of change of environmental conditions, i.e. the so called adaptive control is&#xD;
      more easily implemented in them. Secondly, &quot;spreading&quot; of oscillations strength along&#xD;
      comparatively wide frequency band takes place in chaotic regime.&#xD;
&#xD;
      When an organism is young and healthy, physiological systems show the elements of chaotic&#xD;
      behavior, i.e. irregularity and chaotic dynamics are the extremely important characteristics&#xD;
      of health. Decrease in changeability and appearance of stable periodicity of Autowave&#xD;
      reverberator are often connected with Autism.&#xD;
&#xD;
      The main purpose is to study brain plasticity (the changes that occur in the brain through&#xD;
      Autowave reverberator) in children with autism. Research suggests that during development,&#xD;
      the brains of children may change in response to their Autowave reverberator differently than&#xD;
      the brains of typically developing individuals. Investigators want to understand why and how&#xD;
      this difference may contribute to the symptoms of autism spectrum disorder (ASD). In this&#xD;
      study, the investigators will be examining the effects of non-invasive neuromodulation SQUED™&#xD;
      series 28.1 home-use for Treatment of Autowave reverberator of Autism.&#xD;
&#xD;
      Integrative Team World Organization of Medical Synergetics (WOMS) - collaborations between&#xD;
      physicians and researchers with expertise in biostatistics, physics, mathematics,&#xD;
      engineering, and computer science.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autowave Reverberator:&#xD;
&#xD;
        1. Proved that, a Autowave Reverberator appears a result of a rupture of Autowave front;&#xD;
           initial conditions - Natal Trauma:&#xD;
&#xD;
           1.1 Proved that, such a rupture may occur, via collision of the Autowave front with a&#xD;
           nonexcitable obstacle - brain injury or injury of vertebral;&#xD;
&#xD;
           1.2 Proved that, such a rupture may occur by loss of excitation in a certain region of&#xD;
           the Active medium - cerebral anoxia;&#xD;
&#xD;
           1.3 Locomotor, Transport and Information functions in the physiological systems, and&#xD;
           Communicative Efforts, Speech, Language and Related Cognitive Functions this is Autowave&#xD;
           processes in Active media.&#xD;
&#xD;
        2. An important feature of reverberators is that these Autowave sources have the highest&#xD;
           frequency. By generating pulses at a maximum frequency such sources force out&#xD;
           self-pacemakers of any other types from the medium. As a result, the Active medium is&#xD;
           filled with only Spiral Autowaves:&#xD;
&#xD;
           2.1 The basic parameters of a reverberator are the frequency of generated waves, the&#xD;
           critical dimension and characteristics of the structure of the kernel, and the velocity&#xD;
           of the kernel in space, at Drift of Spiral Autowaves and/or Annihilation of Spiral&#xD;
           Autowaves, or Multiplication of Spiral Autowaves;&#xD;
&#xD;
           2.2 Commonly, there are two characteristic regions in a reverberator: a kernel having an&#xD;
           excitation &quot;tongue&quot; entering it and Spiral Autowaves generated by the kernel - one&#xD;
           spiral/two spirals/three spirals/four spirals; central filament of the Autowaves-branch&#xD;
           rotates Left/Right;&#xD;
&#xD;
           2.3 The kernel can have the form of a circle or a ring, a so-called &quot;anomalous&quot; kernel.&#xD;
           If the source drifts, the form of the kernel is involved and can hardly be determined&#xD;
           unambiguously.&#xD;
&#xD;
        3. Proved that, the reverberator is not tied to any structure in the Active medium:&#xD;
&#xD;
           3.1 Proved that, due to this property, reverberators can Appear and Disappear in the&#xD;
           different Endoderm/Mesoderm/Ectoderm of the Active media, and at different locations of&#xD;
           the Active medium;&#xD;
&#xD;
           3.2 Proved that, due to this property, reverberators can Appear and Disappear in the&#xD;
           Ectodermal Active media - Brain/spinal cord/hair/Skin; central filament of the&#xD;
           endogenous Brain branch/exogenous Skin-branch;&#xD;
&#xD;
           3.3 Proved that, reverberators can Observe on the skin, Spiral Autowaves generated by&#xD;
           the kernel - one spiral/two spirals/three spirals/four spirals; central filament of the&#xD;
           Pileous-branch rotates Left/Right.&#xD;
&#xD;
        4. Proved, Center of Synergetics/Dr. Synergetic (the name of a new physician - Nonlinear&#xD;
           Control of Autowaves chaos in Active media), Nonlinear Control of Autowaves&#xD;
           reverberators:&#xD;
&#xD;
           4.1 Proved, Nonlinear Control of Autowaves reverberators: Hysteresis of Spiral&#xD;
           Autowaves, Drift of Spiral Autowaves and Annihilation of Spiral Autowaves.&#xD;
&#xD;
        5. Treatment of Autowave Reverberator of Autism (this will be administered by Presence of&#xD;
           Clinical protocol CRF-SQUED™):&#xD;
&#xD;
      5.1 Diagnostics of Autowave reverberators and Mathematical Modeling of Autowave reverberators&#xD;
      in Active media + Algorithmic approach;&#xD;
&#xD;
      5.2 Computational Simulation of Autowave reverberator and Mathematical Modeling of treatment&#xD;
      code (Trade Secret) + creation Active medium SQUED™ for a patient;&#xD;
&#xD;
      5.3 Recording for a patient of treatment code (Trade Secret) on the Image Converter/Sound&#xD;
      Converter/Electromagnetic Converter + Autowave regime: Hysteresis of Spiral Autowaves; Drift&#xD;
      of Spiral Autowaves; Annihilation of Autowave reverberator;&#xD;
&#xD;
      5.4 SQUED™ Treatment of Autowave reverberator of Autism (Novel type energy/Non-invasive) +&#xD;
      Semiconducting Quantum Excitonic Device - artificial active medium, where the processes of&#xD;
      self-organization lead to creation and converter of Autowaves energy.&#xD;
&#xD;
      Some autowaves have the properties of quasi-particles!&#xD;
&#xD;
      Participants in the study will be asked to do the following things:&#xD;
&#xD;
        -  Grant permission for the researchers to view medical/psychological and/or educational&#xD;
           and/or speech records associated with the diagnosis of autism.&#xD;
&#xD;
        -  Complete a questionnaire and provide a health history.&#xD;
&#xD;
        -  Complete evaluations by our study team to assess the diagnosis and gain a clearer&#xD;
           understanding of the participant's current functioning.&#xD;
&#xD;
        -  Give to our study team of Photo of Autowave Reverberator - Presence on the Skin of the&#xD;
           interruption of Autowave front (interruption of hair separatrix - dorsal/ventral) and/or&#xD;
           Photo of Spiral Autowaves, generated by the kernel of Autowave Reverberator - the kernel&#xD;
           having an excitation &quot;tongue&quot;.&#xD;
&#xD;
        -  Give to our study team of Graphics on tracing paper of Autowave Reverberator - Presence&#xD;
           on the Skin of the interruption of Autowave front (interruption of hair separatrix -&#xD;
           dorsal/ventral) and/or Graphics on tracing paper of Spiral Autowaves, generated by the&#xD;
           kernel of Autowave Reverberator - the kernel having an excitation &quot;tongue&quot;.&#xD;
&#xD;
        -  Complete several tasks and training interventions that involve such things as learning&#xD;
           new words or pictures, saying words out loud, or naming objects.&#xD;
&#xD;
        -  Complete several tasks and training interventions that involve such things as creation&#xD;
           pictures iSQUED™ and music compositions sSQUED™.&#xD;
&#xD;
        -  Give permission to audio and video-tape test sessions for later scoring and observation.&#xD;
&#xD;
        -  Give permission to audio or video-tape in the Home environment or classroom using&#xD;
           non-intrusive audio-visual recording devices.&#xD;
&#xD;
        -  Participate in computerized tasks of Image converter SQUED™ (iSQUED™). The&#xD;
           software/device poses no risk and is non-invasive.&#xD;
&#xD;
        -  Participate in computerized tasks of Sound converter SQUED™ (sSQUED™). The&#xD;
           software/device poses no risk and is non-invasive.&#xD;
&#xD;
        -  Participate in computerized tasks of Electromagnetic converter SQUED™ (eSQUED™). The&#xD;
           device/software poses no risk and is non-invasive.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2017</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SQUED™ software of patient</measure>
    <time_frame>Personal Autowave Diagnostics/Personal Autowave Therapy - through study completion, an average of 1 year</time_frame>
    <description>This will be administered by Presence of Clinical protocol CRF-SQUED™and creation Active medium SQUED™ for a patient.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Autistic Disorder</condition>
  <condition>Autism Spectrum Disorder</condition>
  <condition>Child Development Disorders, Pervasive</condition>
  <condition>Neurodevelopmental Disorders</condition>
  <condition>Mental Disorders</condition>
  <condition>Asperger's Syndrome</condition>
  <condition>Neurobehavioral Manifestations</condition>
  <condition>Nervous System Diseases</condition>
  <arm_group>
    <arm_group_label>Autism</arm_group_label>
    <description>Individuals with autism will have either Image converter (iSQUED™) for Hysteresis of Spiral Autowaves, Sound converter (sSQUED™) for Drift of Spiral Autowaves or Electromagnetic converter (eSQUED™) for Annihilation Autowave reverberator.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SQUED™ series 28.1 home-use</intervention_name>
    <description>Semiconducting QUantum Excitonic Device - artifificial active medium, where the processes of self-organization lead to creation and converter of Autowaves energy.&#xD;
Some autowaves have the properties of quasi-particles!</description>
    <arm_group_label>Autism</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be 1 month to 21 years of age, diagnosed with autism by independent&#xD;
        clinicians and confirmed by formal assessment (e.g., CDI, ADOS, Bayley, Sensory Profile),&#xD;
        and with receptive and expressive vocabulary levels of ≥ 3 years age-equivalent, as&#xD;
        assessed by standardized measures. Additionally, the Autism Diagnostic Interview will be&#xD;
        administered to caregivers in order to appropriately identify specific areas (regarding&#xD;
        speech, language and cognition) in which participants are experiencing the most difficulty.&#xD;
        The experimental group will consist of children (Infant, Child and Adolescent) with&#xD;
        Autowave reverberators of Autism (n = 80): 1/2/3/4 armed/Left/Right_Spiral Autowaves.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of autism or related conditions.&#xD;
&#xD;
          -  History of Late complications at Natal Trauma:&#xD;
&#xD;
               1. Cerebral level of Natal Trauma - brain injury;&#xD;
&#xD;
               2. Cervical level of Natal Trauma - injury of vertebral;&#xD;
&#xD;
               3. Cerebral anoxia.&#xD;
&#xD;
          -  Identified language deficit(s) and/or other cognitive or behavioral impairments (which&#xD;
             will be specific to each sub-study).&#xD;
&#xD;
          -  Adequate ability to perform the research tasks set for the Age level:&#xD;
&#xD;
               1. Infant - greater than 1 month to 2 years of age;&#xD;
&#xD;
               2. Child - greater than 2 to 12 years of age;&#xD;
&#xD;
               3. Adolescent - greater than 12 through 21 years of age.&#xD;
&#xD;
          -  Presence on the Skin of the interruption of Autowave front (interruption of hair&#xD;
             separatrix - dorsal/ventral) and/or of the Autowave Reverberators:&#xD;
&#xD;
               1. Photo of Spiral Autowaves, generated by the kernel of Autowave Reverberator - the&#xD;
                  kernel having an excitation &quot;tongue&quot;;&#xD;
&#xD;
               2. Graphics on tracing paper of Spiral Autowaves, generated by the kernel of&#xD;
                  Autowave Reverberator - the kernel having an excitation &quot;tongue&quot;.&#xD;
&#xD;
          -  Presence of Clinical protocol CRF-SQUED™:&#xD;
&#xD;
               1. Diagnostics of Autowave reverberators and Nonlinear Control of Autowave&#xD;
                  reverberators in Active media (Autowave interaction of patient - Algorithmic&#xD;
                  approach);&#xD;
&#xD;
               2. Mathematical Modeling of Autowave Reverberator and Computational Simulation of&#xD;
                  the treatment code (Trade Secret), and creation Active medium SQUED™ for a&#xD;
                  patient;&#xD;
&#xD;
               3. Recording for a patient of treatment code (Trade Secret) - Autowave regime:&#xD;
                  Hysteresis of Spiral Autowaves; Drift of Spiral Autowaves; Annihilation of&#xD;
                  Autowave reverberator.&#xD;
&#xD;
          -  Magnetogram of region of Home-use and Geographic coordinates of Home-use.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Peripheral blindness - precludes use of Image converter SQUED™ (iSQUED™).&#xD;
&#xD;
          -  Peripheral deafness - precludes use of Sound converter SQUED™ (sSQUED™).&#xD;
&#xD;
          -  Any implanted metal device - precludes use of Electromagnetic converter SQUED™&#xD;
             (eSQUED™).&#xD;
&#xD;
          -  Any implanted cardiac pacemaker - precludes use of Electromagnetic converter SQUED™&#xD;
             (eSQUED™).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuliya Yaroshuk, M.D.s. Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yuriy Fihol, M.D.s. Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic of Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology of the World Organization of Medical Synergetics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuliya Yaroshuk, M.D.s. Ph.D.</last_name>
    <phone>502-338-0861</phone>
    <email>Dr.Yuliya.Yaroshuk@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yuriy Fihol, M.D.s. Ph.D.</last_name>
    <phone>+ 38 067-717-6873</phone>
    <email>Dr.Yuriy.Fihol@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40228</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuliya Yaroshuk, M.D.s. Ph.D., Asso. Prof. M.S.</last_name>
      <phone>502-338-0861</phone>
      <email>Dr.Yuliya.Yaroshuk@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Heorhiy A. Shynkarenko, Prof. Dr. Phys. Math. S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yuriy Fihol, M.D.s. Ph.D., Asso. Prof. M.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Volodymyr D. Vovk, Asso. Prof. Ca. Phys. Math. S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology of the World Organization of Medical Synergetics</name>
      <address>
        <city>Lviv</city>
        <state>Solonka Village, Urozayna Street 41</state>
        <zip>81131</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuriy Fihol, M.D.s. Ph.D., Asso. Prof. M.S.</last_name>
      <phone>+ 38 067-717-6873</phone>
      <email>Dr.Yuriy.Fihol@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Volodymyr D. Vovk, Asso. Prof. Ca. Phys. Math. S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yuliya Yaroshuk, M.D.s. Ph.D., Asso. Prof. M.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Heorhiy A. Shynkarenko, Prof. Dr. Phys. Math. S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://med-synergetics.org/en/discovery</url>
    <description>Yaroshuk's MEGA-DISCOVERY · DIAGNOSTICS · TREATMENT</description>
  </link>
  <link>
    <url>http://itp1.uni-stuttgart.de/en/institut/arbeitsgruppen/haken/cos.php</url>
    <description>Center of Synergetics, Universität Stuttgart, Germany</description>
  </link>
  <link>
    <url>http://dr-synergetic.name</url>
    <description>Dr. Synergetic - Nonlinear Control of Autowaves chaos in Active Media</description>
  </link>
  <link>
    <url>http://www.google.com/maps/place/49%C2%B045'56.6%22N+23%C2%B059'53.7%22E/@49.7659965,23.9979761,690m/data=!3m1!1e3!4m5!3m4!1s0x0:0x0!8m2!3d49.7657222!4d23.99825</url>
    <description>Headquarters of World Organization of Medical Synergetics, Lviv - Solonka ( 49°45'56.6&quot;N 23°59'53.7&quot;E )</description>
  </link>
  <link>
    <url>http://plus.google.com/communities/101353132492658668565</url>
    <description>Yaroshuk's Scientific Medical School</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/gumoniter/d1</url>
    <description>Humanitarian programs - Yaroshuk's Scientific Medical School and World Organization of Medical Synergetics</description>
  </link>
  <link>
    <url>http://www.springer.com/in/book/9789027723796</url>
    <description>Autowave processes in Medicine - book</description>
  </link>
  <link>
    <url>https://www.amazon.com/Self-Organized-Biological-Dynamics-Nonlinear-Control/dp/0521026075</url>
    <description>Nonlinear Control - book</description>
  </link>
  <link>
    <url>http://www.scholarpedia.org/article/Drift_of_spiral_waves</url>
    <description>Drift of spiral wave in excitable media</description>
  </link>
  <link>
    <url>http://cdn.intechopen.com/pdfs-wm/46160.pdf</url>
    <description>Some classic types of reverberator evolution - Hysteresis width</description>
  </link>
  <link>
    <url>http://iopscience.iop.org/article/10.1088/1367-2630/10/1/015003</url>
    <description>Efficient control of spiral wave location in an excitable medium</description>
  </link>
  <link>
    <url>http://en.wikipedia.org/wiki/Autowave_reverberator</url>
    <description>Autowave reverberator</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/qualitive-description/a1</url>
    <description>A Periodically rotating Reverberators: a qualitative description</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/qualitive-description/a3</url>
    <description>The characteristics of the kernel</description>
  </link>
  <link>
    <url>https://en.wikipedia.org/wiki/Excitable_medium</url>
    <description>Modelling excitable media</description>
  </link>
  <link>
    <url>http://www.scholarpedia.org/article/Excitable_media</url>
    <description>Excitable media</description>
  </link>
  <link>
    <url>https://archive.org/details/nasa_techdoc_19710012507</url>
    <description>Theory of bifurcations of dynamic systems on a plane - eBook &quot;Mathematical on the Skin&quot;</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/ectoderm/e3</url>
    <description>Ectoderm - &quot;Mathematical on the Skin&quot;</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/qualitive-description/a2</url>
    <description>Photo of Autowave reverberators - old archive</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/squed/b6</url>
    <description>Photo of Autowave reverberators - old archive</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/squed/b7</url>
    <description>Photo of Autowave reverberators - old archive</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/squed/b8</url>
    <description>The Multiplication of Autowave reverberators</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/qualitive-description/a4</url>
    <description>The Multiplication of Autowave reverberators</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/squed/b2</url>
    <description>Annihilation of Autowave reverberator - Stages of work with SQUED™</description>
  </link>
  <link>
    <url>http://med-synergetics.org/en/squed/b3</url>
    <description>Annihilation of Autowave reverberator - Stages of work with SQUED™</description>
  </link>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>July 13, 2017</study_first_submitted>
  <study_first_submitted_qc>July 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2017</study_first_posted>
  <last_update_submitted>November 24, 2017</last_update_submitted>
  <last_update_submitted_qc>November 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Yaroshuk's MEGA-DISCOVERY · DIAGNOSTICS · TREATMENT</keyword>
  <keyword>Yaroshuk's Scientific Medical School</keyword>
  <keyword>Center of Synergetics</keyword>
  <keyword>Controlling spatiotemporal chaos/Dr. Synergetic</keyword>
  <keyword>Autowave processes in Medicine</keyword>
  <keyword>Autowave Reverberator</keyword>
  <keyword>Bifurcation of Dynamic systems on a plane</keyword>
  <keyword>Spiral Autowaves</keyword>
  <keyword>Drift of Spiral Autowaves</keyword>
  <keyword>Excitable medium and Cellular Automata</keyword>
  <keyword>Stochastic Resonance and Coherence Resonance</keyword>
  <keyword>Autowaves/SQUED</keyword>
  <keyword>Theory of Semiconducting QUantum Excitonic Device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Neurobehavioral Manifestations</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Neurodevelopmental Disorders</mesh_term>
    <mesh_term>Asperger Syndrome</mesh_term>
    <mesh_term>Developmental Disabilities</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>This will be administered by Presence of Clinical protocol CRF-SQUED™ and creation Active medium SQUED™ of Patient.</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Personal Autowave Diagnostics/Personal Autowave Therapy</ipd_time_frame>
    <ipd_access_criteria>SQUED™ software - Active medium SQUED™ of Patient</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

